Graycell Advisors (GraycellAdvisors.com and PrudentBiotech.com) publishes growth stock newsletters. The quantitative, algorithm-driven model portfolios have a track record of significantly and consistently outperforming the market. The articles on Market Outlook, Smallcap market segment and Biotech sector, are written by Tarun Chandra, CFA, who has experience as an Equity Analyst on the Sellside and Buyside, and experience in Corporate Strategy and Finance working on Main Street. Fundamentals drive valuations. Technicals assist in timing. Stocks mentioned in the report may be now or in the past, part of the growth portfolios recommended by Graycell Advisors and related entities.
The Green River Intrinsic Value fund is a relatively concentrated, long/short equity strategy. The fund seeks long-term absolute returns investing in deeply mispriced securities which are identified through a careful process of methodical fundamental research and due diligence.